Skip to main navigation Skip to search Skip to main content

CORE - Open-Label Extension Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Patients with Severe Hypertriglyceridemia (SHTG)

Project: Research

Project Details

StatusFinished
Effective start/end date1/11/24 → 1/03/25